Michael P. Gustafson PhD

Michael P. Gustafson, Ph.D., is the scientific director of the Nyberg Human Cellular Therapy Laboratory at Mayo Clinic's Arizona campus. Dr. Gustafson and his team are focused on developing and translating cell- and immune-based therapies for the treatment of cancer, autoimmunity, and other diseases into clinical trials. Dr. Gustafson's research also encompasses understanding systemic immunity in humans, how cancer alters the immune landscape in humans, and how physical activity may be used to improve immune responses to immunotherapy.